Cinven nabs Labco as a fourth pulled IPO morphs to PE buyout

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cinven nabs Labco as a fourth pulled IPO morphs to PE buyout

Pharmaceutical 230x150

Cinven announced on Thursday that it would buy Labco, the French medical diagnostics firm, the third time this year that a private equity firm has swept up a company that had failed to IPO, or where the flotation had found weak demand.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article